TMBR
Market cap | $1.18 Million |
---|---|
Enterprise Value | $-798,315.00 |
Dividend Yield | $0 (0%) |
Earnings per Share | $-9.19 |
Beta | -0.65 |
Outstanding Shares | 3,078,297 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.04 |
---|---|
PEG | 0.06 |
Price to Sales | - |
Price to Book Ratio | -0.34 |
Enterprise Value to Revenue | -9.6 |
Enterprise Value to EBIT | 0.05 |
Enterprise Value to Net Income | 0 |
Total Debt to Enterprise | -0.68 |
Debt to Equity | -0.21 |
No data
No data
Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-actio...